kabutan

TSUMURA & CO.(4540) Summary

4540
TSE Prime
TSUMURA & CO.
3,843
JPY
+51
(+1.34%)
Dec 15, 3:19 pm JST
24.78
USD
Dec 15, 1:19 am EST
Result
PTS
outside of trading hours
3,845
Dec 15, 3:17 pm JST
Summary Chart Historical News Financial Result
PER
11.7
PBR
0.97
Yield
3.75%
Margin Trading Ratio
6.74
Stock Price
Dec 15, 2025
Opening Dec 15, 9:00 am
3,836 JPY 24.61 USD
Previous Close Dec 12
3,792 JPY 24.34 USD
High Dec 15, 9:01 am
3,857 JPY 24.80 USD
Low Dec 15, 9:00 am
3,805 JPY 24.41 USD
Volume
222,200
Trading Value
0.85B JPY 5.50M USD
VWAP
3839.25 JPY 24.76 USD
Minimum Trading Value
384,300 JPY 2,478 USD
Market Cap
0.29T JPY 1.90B USD
Number of Trades
847
Liquidity & Number of Trades
As of Dec 15, 2025
Liquidity
High
1-Year Average
1,430
1-Year High May 13, 2025
8,192
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 27,600 134,100 4.86
Nov 28, 2025 27,100 138,800 5.12
Nov 21, 2025 27,300 138,700 5.08
Nov 14, 2025 33,900 150,900 4.45
Nov 7, 2025 31,200 232,000 7.44
Company Profile
TSUMURA & CO. is the leading company specializing in Kampo medicines, expanding its focus on medications for the elderly, cancer patients, and women's health. The company is also developing its business in China.
Sector
Pharmaceuticals
TSUMURA & CO. primarily engages in the manufacture and sale of Kampo medicines, offering both prescription and over-the-counter pharmaceuticals. The company has established an integrated production system from the cultivation of raw medicinal herbs to product manufacturing, ensuring thorough quality control. In Japan, TSUMURA & CO. has secured its position as the undisputed top manufacturer of prescription Kampo preparations. In recent years, the company has been actively expanding into the Chinese market, strengthening its local production and sales capabilities through capital and business alliances with local enterprises. Furthermore, TSUMURA & CO. is advancing its global business operations, including drug development in the United States and cultivation of raw medicinal herbs in Laos. The company focuses on promoting Kampo medicine and developing evidence-based Kampo preparations to address the diversifying needs in healthcare.